Everolimus (Compound)

Synonyms:001, RAD, 40-O-(2-hydroxyethyl)-rapamycin, 40-O-(2-Hydroxyethyl)rapamycin, Afinitor, Certican, Everolimus, RAD, RAD 001, RAD, SDZ, RAD001, SDZ RAD, SDZ-RAD, Zortress, 159351-69-6, Votubia, 42-O-(2-Hydroxyethyl)rapamycin, RAD-001, Afinitor Disperz, CHEBI:68478, Rapamycin, 42-O-(2-hydroxyethyl)-, 9HW64Q8G6G, DTXSID0040599, RAD 666, RAD-666, Everolimus (INN), NCGC00167512-01, Everolimus (RAD001), EVEROLIMUS [INN], (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-12-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone, Everolimus [USAN], everolimusum, NSC733504, SDZRAD, XIENCE V, EVEROLIMUS [MI], Everolimus - RAD001, EVEROLIMUS [JAN], EVEROLIMUS [VANDF], EVEROLIMUS [MART.], SCHEMBL4378, EVEROLIMUS [USP-RS], EVEROLIMUS [WHO-DD], NVP-RAD001, UNII-9HW64Q8G6G, EVEROLIMUS [EMA EPAR], Everolimus [USAN:INN:BAN], NVP-RAD-001, Everolimus, analytical standard, GTPL5889, RAD-001C, CHEMBL1908360, DTXCID8020599, EVEROLIMUS [ORANGE BOOK], HSDB 8255, EVEROLIMUS [EP MONOGRAPH], Everolimus; RAD001; SDZ-RAD, 42-O-(2-Hydroxyethyl)-rapamycin, EX-A2057, Tox21_112510, BDBM50088378, AKOS015850977, CS-0064, DB01590, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, AS-16971, HY-10218, CAS-159351-69-6, Q421052, Q-101413, BRD-K13514097-001-01-2, BRD-K13514097-001-05-3, dihydroxy-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-dimethoxy-hexamethyl-[?]pentone
Pubchem:PUBCHEM:6442177
Id:099d88ed-c7d0-5f97-b81b-4c7f6e3fe2fd
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Everolimus's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Everolimus.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Everolimus.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.